Severe gastrointestinal involvement in systemic sclerosis: Report of five cases and review of the literature

Seminars in Arthritis and Rheumatism

Volumn 34, Issue 4, 2005, Pages 689-702

  Jaovisidha, Kanyakorn ^a   Csuka, M E ^b   Almagro, Urias A ^b   Soergel, Konrad H ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

gastrointestinal diseases; gastrointestinal motility; scleroderma; systemic sclerosis

Indexed keywords

ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; BRAIN DERIVED GROWTH FACTOR; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CISAPRIDE; DOMPERIDONE; DOPAMINE RECEPTOR BLOCKING AGENT; ERYTHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; IRON; LAXATIVE; METOCLOPRAMIDE; NEUROTROPHIN 3; OCTREOTIDE; PROKINETIC AGENT; PROTON PUMP INHIBITOR; PRUCALOPRIDE; SOMATOSTATIN DERIVATIVE; TEGASEROD; URSODEOXYCHOLIC ACID;

ANTIREFLUX OPERATION; ANUS; ARGON LASER; ASPIRATION PNEUMONIA; AUTOPSY; BACTERIAL OVERGROWTH; BILIARY TRACT DISEASE; CAUSE OF DEATH; CLINICAL FEATURE; COLON DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; DATA BASE; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE SEVERITY; ENDOSCOPIC THERAPY; ESOPHAGUS DISEASE; EXTRAPYRAMIDAL SYMPTOM; FECES INCONTINENCE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; HEART DISEASE; HEART VENTRICLE ARRHYTHMIA; HISTOPATHOLOGY; HUMAN; INTESTINE PSEUDOOBSTRUCTION; IRON DEFICIENCY ANEMIA; LITERATURE; LIVER DISEASE; LONG QT SYNDROME; MALABSORPTION; MALNUTRITION; MEDLINE; MORBIDITY; MORTALITY; MOUTH CAVITY; MOUTH HYGIENE; PALLIATIVE THERAPY; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; QUALITY OF LIFE; RECTUM DISEASE; REVIEW; SCLERODERMA; SIDE EFFECT; SMALL INTESTINE DISEASE; STOMACH DISEASE; STOMACH PARESIS; SURVIVAL; SYSTEMIC SCLEROSIS;

EID: 13244262707     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2004.08.009     Document Type: Article

References (95)

1. T.A. Medsger Jr Systemic sclerosis (Scleroderma) clinical aspects W.J. Koopman Arthritis and Allied Conditions 2001 Lippincott Williams & Wilkins Philadelphia, PA 1590 1624
2. E.C. Leroy, C.M. Black, R. Fleischmajer, S. Jablonska, T. Krieg, T.A. Medsger Jr Scleroderma (systemic sclerosis) classification, subsets and pathogenesis J Rheumatol 15 1988 202 205
3. A.J. Geirsson, F.A. Wollheim, A. Akesson Disease severity of 100 patients with systemic sclerosis over a period of 14 years using a modified Medsger scale Ann Rheum Dis 60 2001 1117 1122
4. V.D. Steen, T.A. Medsger Jr Severe organ involvement in systemic sclerosis with diffuse scleroderma Arthritis Rheum 43 2000 2437 2444
5. T.A. Medsger Jr, A.J. Silman, V.D. Steen, C.M. Black, A. Akesson, P.A. Bacon A disease severity scale for systemic sclerosis development and testing J Rheumatol 26 1999 2159 2167
6. P.H. Clements FurstDE Systemic Sclerosis second ed 2004 Lippincott Williams & Wilkins Philadelphia, PA
7. A.T. Masi, G.P. Rodnan, T.A. Medsger Jr, R.D. Altman, W.A. D'Angelo, J.F. Fries Preliminary criteria for the classification of systemic sclerosis (scleroderma) Arthritis Rheum 23 1980 581 590
8. T.A. Medsger Jr Classification, Prognosis P.J. Clements D.E. Furst Systemic Sclerosis 2004 Lippincott Williams & Wilkins Philadelphia, PA 17 28
9. M. Hebbar, A. Janin, D. Huglo, M.C. Copin, R. Lafyatis, B. Devulder Xerostomia in systemic sclerosis systematic evaluation by salivary scintigraphy and lip biopsy in thirty-four patients Arthritis Rheum 37 1994 439 443
10. G.K. Spackman Scleroderma what the general dentist should know Gen Dent 47 1999 576 579
11. G.A. Scardina, P. Messina Systemic sclerosis description and diagnostic role of the oral phenomena Gen Dent 52 2004 42 47
12. K.R. Devault Extraesophageal symptoms of GERD Cleve Clin J Med 70 Suppl. 5 2003 S20 S32
13. G.C. Jiranek, J.E. Bredfelt Organ involvement gut and hepatic manifestations P.J. Clements D.E. Furst Systemic Sclerosis 1996 Williams & Wilkins Baltimore, MD 453 482
14. A.D. Rossa, G. Valentini, S. Bombardieri, W. Bencivelli, A.J. Silman, S. D'Angelo European multicenter study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centers Ann Rheum Dis 60 2001 585 591
15. B.J. Zamost, J. Hirschberg, A.F. Ippoliti, D.E. Furst, P.J. Clements, W.M. Weinstein Esophagitis in scleroderma Gastroenterology 92 1987 421 428
16. S. Weston, M. Thumshirn, J. Wiste, M. Camilleri Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders Am J Gastroenterology 93 1998 1085 1089
17. P. Ipsen, H. Egekvist, K. Aksglaede, H. Zachariae, P. Bjerring, P. Thommesen Oesophageal manometry and video-radiology in patients with systemic sclerosis a retrospective study of its clinical value Acta Derm Venereol 80 2000 130 133
18. G. Lock, A. Holstege, B. Lang, J. Scholmerich Gastrointestinal manifestations of progressive systemic sclerosis Am J Gastroenterol 92 1997 763 771
19. J.C. Yarze Esophageal dysmotility and its relation to systemic sclerosis variant Am J Gastroenterol 93 1998 2630 2631
20. Y. Niv, S. Abu-Avid, A. Yelin, Y. Liberman Barrett's epithelium and esophageal adenocarcinoma in scleroderma Am J Gastroenterol 83 1988 792 793
21. M.A. Contreras, C. Salas, J.L. Andreu, J. Mulero Cytomegalovirus esophagitis as a treatable complication of systemic sclerosis J Clin Rheumatol 7 2001 384 387
22. F. Mearin, V. Fonollosa, M. Vilardell, J.R. Malagelada Mechanical properties of the gastro-esophageal junction in health, achalasia, and scleroderma Scand J Gastroenterol 7 2000 705 710
23. A. Bestetti, F. Carola, L. Conciato, B. Marasini, G.L. Tarolo Esophageal scintigraphy with a semisolid meal to evaluate esophageal dysmotility in systemic sclerosis and Raynaud's phenomenon J Nucl Med 40 1999 77 84
24. G.J. Maddern, M. Horowitz, G.G. Jamieson, B.E. Chatterton, P.J. Collins, P. Roberts-Thomson Abnormalities of esophageal and gastric emptying in progressive systemic sclerosis Gastroenterology 87 1984 922 926
25. I. Marie, H. Levesque, P. Ducrotte, P. Denis, M.-F. Hellot, J. Benichou Gastric involvement in systemic sclerosis a prospective study Am J Gastroenterol 96 2001 77 83
26. T. Marycz, S.M. Muehldorfer, M.S. Gruschwitz, A. Katalinic, C. Herold, C. Ell Gastric involvement in progressive systemic sclerosis electrogastrographic and sonographic findings Eur J Gastroenterol Hepatol 11 1999 1151 1156
27. A. Duchini, S.L. Sessoms Gastrointestinal hemorrhage in patients with systemic sclerosis and CREST syndrome Am J Gastroenterol 93 1998 1453 1456
28. G. Costamagna, S.K. Shah, M.E. Riccioni, F. Foschia, M. Mutignani, V. Perri A prospective trial comparing small bowel radiographs and video capsule endoscopy for suspected small bowel disease Gastroenterology 123 2002 999 1005
29. J.S. Scolapio, E.L. Matteson The watermelon stomach in scleroderma Arthritis Rheum 36 1993 724 725
30. O. Elkayam, M. Oumanski, M. Yaron, D. Caspi Watermelon stomach following and preceding systemic sclerosis Semin Arthritis Rheum 30 2000 127 131
31. K.T. Calamia, J.S. Scolapio, T.R. Viggiano Endoscopic YAG laser treatment of watermelon stomach (gastric antral vascular ectasia) in patients with systemic sclerosis Clin Exp Rheumatol 18 2000 605 608
32. P.J. Pickhardt The "hide-bound" bowel sign Radiology 213 1999 837 838
33. R.W. Sjogren Gastrointestinal features of scleroderma Curr Opin Rheumatol 8 1996 569 575
34. W.M. Weinstein, B.M. Kadell The gastrointestinal tract in systemic sclerosis P.J. Clements D.E. Furst Systemic Sclerosis 2004 Lippincott Williams & Wilkins Philadelphia, PA 293 307
35. S.A. Kaye, A.M. Seifalian, S.G. Lim, G. Hamilton, C.M. Black Ischaemia of the small intestine in patients with systemic sclerosis Raynaud's phenomenon or chronic vasculopathy? Q J Med 87 1994 495 500
36. J.E. Pope, J.R. Seibold International Conference on Systemic Sclerosis J Rheumatol 26 1999 938 944
37. J.A. Gomez-Puerta, V. Gil, B.V. Cervera, R. Miquel, S. Jimenez, M. Ramos-Casals, J. Font Coeliac disease associated with systemic sclerosis Ann Rheum Dis 63 2004 104 105
38. M. Di Stefano, G. Veneto, S. Malservisi, G.R. Corazza Small intestine bacterial overgrowth and metabolic bone bisease Dig Dis Sci 46 2001 1077 1082
39. S.A. Kaye, S.G. Lim, M. Taylor, S. Patel, S. Gillespie, C.M. Black Small bowel bacterial overgrowth in systemic sclerosis detection using direct and indirect methods and treatment outcome Br J Rheumatol 34 1995 265 269
40. J.A. Perman, S. Modler, R.G. Barr, P. Rosenthal Fasting breath hydrogen concentration normal values and clinical application Gastroenterology 87 1984 1358 1363
41. C.E. King, P.P. Toskes, J.C. Spivey, E. Lorenz, S. Welkos Detection of small intestine bacterial overgrowth by means of a 14C-D-xylose breath test Gastroenterology 77 1979 75 82
42. M. Trezza, K. Krogh, H. Egekvist, P. Bjerring, S. Laurberg Bowel problems in patients with systemic sclerosis Scand J Gastroenterol 34 1999 409 413
43. N.M. de Souza, A.D. Williams, H.J. Wilson, D.J. Gilderdale, G.A. Coutts, C.M. Black Fecal incontinence in scleroderma assessment of the anal sphincter with thin-section endoanal MR imaging Radiology 208 1998 529 535
44. B.W. Jaffin, P. Chang, H. Spiera Fecal incontinence in scleroderma. Clinical features, anorectal manometric findings, and their therapeutic implications J Clin Gastroenterol 25 1997 513 517
45. J. Hamel-Roy, G. Devroede, P. Arhan, L. Tetreault, A. Duranceau, H.-A. Menard Comparative esophageal and anorectal motility in scleroderma Gastroenterology 88 1985 1 7
46. G. Lock, M. Zeuner, B. Lang, R. Hein, J. Scholmerich, A. Holstege Anorectal function in systemic sclerosis correlation with esophageal dysfunction? Dis Colon Rectum 40 1997 1328 1335
47. U. Haque, J. Yardley, M. Talamini, F. Wigley Colon stricture and volvulus in a patient with scleroderma J Rheumatol 26 1999 2268 2272
48. S.C. Hung, H.Y. Lin Intestinal obstruction associated with scleroderma not always pseudoobstruction Clin Exp Rheumatol 18 2000 102
49. R.D. Miercort, F.G. Merrill Pneumatosis and pseudoobstruction in scleroderma Radiology 92 1969 359 362
50. W. Sequeira Pneumatosis cystoides intestinalis in systemic sclerosis and other diseases Semin Arthritis Rheum 19 1990 269 277
51. S. Akimoto, O. Ishikawa, Y. Muro, H. Takagi, T. Tamura, Y. Miyachi Clinical and immunological characterization of patients with systemic sclerosis overlapping primary biliary cirrhosis a comparison with patients with systemic sclerosis alone J Dermatol 26 1999 18 22
52. M.H.I. Lopes, E. Ludwig, B.B. Do Amaral, C.F. Francisconi, C.A. Von Muhlen Motor activity of the gallbladder in systemic sclerosis Am J Gastroenterol 94 1999 3487 3491
53. S. Jimenez, C.T. Derk Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis Ann Int Med 140 2004 37 50
54. C. Piasecki, J. Chin, L. Greenslade Endoscopic detection of ischaemia with a new probe indicates low oxygenation of gastric epithelium in portal hypertensive gastropathy Gut 36 1995 654 656
55. M.L. Russell, D. Friesen, R.D. Henderson, W.M. Hanna Ultrastructure of the esophagus in scleroderma Arthritis Rheum 25 1982 1117 1123
56. S. Rose, M.A. Young, J.C. Reynolds Gastrointestinal manifestation of scleroderma Gastroenterol Clin NA 27 1998 563 594
57. A. Malandrini, E. Selvi, M. Villanova, G. Berti, L. Sabadini, C. Salvadori Autonomic nervous system and smooth muscle cell involvement in systemic sclerosis ultrastructural study of 3 cases J Rheumatol 27 2000 1203 1206
58. P.J. Clements, R. Becvar, A.A. Drosos, L. Ghattas, A. Gabrielli Assessment of gastrointestinal involvement Clin Exp Rheumatol 21 Suppl. 29 2003 S15 S18
59. A. Akesson, R. Ekman, H. Prytz, F. Sundler Tissue concentrations of gastrointestinal regulatory peptides in the duodenal mucosa in systemic sclerosis Clin Exp Rheumatol 16 1998 141 148
60. S. Howe, E.Y. Eaker, J.E. Sallustio, C. Peebles, E.M. Tan, R.C. Williams Jr Antimyenteric neuronal antibodies in scleroderma J Clin Invest 94 1994 761 770
61. E.Y. Eaker, J.G. Kuldau, G.N. Verne, S.O. Ross, J.E. Sallustio Myenteric neuronal antibodies in scleroderma passive transfer evokes alterations in intestinal myoelectric activity in a rat model J Lab Clin Med 133 1999 551 556
62. G.N. Verne, J.E. Sallustio, E.Y. Eaker Anti-myenteric neuronal antibodies in patients with achalasia. A prospective study Dig Dis Sci 42 1997 307 313
63. R. Gonzalez, M. Storr, H. Bloching, M. Seige, R. Ott, H.D. Allescher Autoantibody profile in progressive systemic sclerosis as markers for esophageal involvement J Clin Gastroenterol 32 2001 123 127
64. F. Goldblatt, T.P. Gordon, S.A. Waterman Antibody-mediated gastrointestinal dysmotility in scleroderma Gastroenterology 123 2002 1144 1150
65. J.L. Poole Occupational and physical therapy P.J. Clements D.E. Furst Systemic Sclerosis 1996 Williams & Wilkins Baltimore 581 590
66. G. Pizzo, G.A. Scardina, P. Messina Effects of a nonsurgical exercise program on the decreased mouth opening in patients with systemic scleroderma Clin Oral Invest 7 2003 175 178
67. T. Adhami, J.E. Richter Twenty-four hour pH monitoring in the assessment of esophageal function Semin Thorac Cardiovasc Surg 13 2001 241 254
68. J.W. Maher, M.P. Hocking, E.R. Woodward Reoperations for esophagitis following failed antireflux procedures Ann Surg 201 1985 723 727
69. L. Bonavina, A. Segalin, U. Fumagalli, A. Peracchia Surgical management of benign stricture from reflux oesophagitis Ann Chir Gynaecol 84 1995 175 178
70. R.C. Heading Should abnormal oesophageal motility in gastro-oesophageal reflux disease (GERD) influence decisions about fundoplication? Gut 50 2002 592 593
71. K.R. Sridhar, R.C. Lange, L. Magyar, I. Soykan, R.W. McCallum Prevalence of impaired gastric emptying of solids in systemic sclerosis diagnostic and therapeutic implications J Lab Clin Med 132 1998 541 546
72. D.A. Johnson, W.E. Drane, J. Curran, S.B. Benjamin, S.J. Chobanian, K. Karvelis Metoclopramide response in patients with progressive systemic sclerosis. Effect on esophageal and gastric motility abnormalities Arch Int Med 147 1987 1597 1601
73. H.D. Allescher, A. Bockenhoff, G. Knapp, M. Wienbeck, J. Hartung Treatment of non-ulcer dyspepsia a meta-analysis of placebo-controlled prospective studies Scan J Gastroenterol 36 2001 934 941
74. B. Drolet, G. Rousseau, P. Daleau, R. Cardinal, J. Turgeon Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorder Circulation 102 2000 1883 1885
75. A. Kahan, S. Chaussade, M. Gaudric, B. Freitag, B. Amor, C.J. Menkes The effect of cisapride on gastro-oesophageal dysfunction in systemic sclerosis a controlled manometric study Br J Clin Pharmacol 31 1991 683 687
76. M. Horowitz, G.J. Maddern, A. Maddox, J. Wishart, B.E. Chatterton, D.J. Shearman Effects of cisapride on gastric and esophageal emptying in progressive systemic sclerosis Gastroenterology 93 1987 311 315
77. A.J. Limburg, A.J. Smit, J.H. Kleibeuker Effects of cisapride on the esophageal motor function of patients with progressive systemic sclerosis or mixed connective tissue disease Digestion 49 1991 156 160
78. S.J. Wang, J.L. La, D.Y. Chen, Y.H. Chen, T.Y. Hsieh, W.Y. Lin Effects of cisapride on oesophageal transit of solids in patients with progressive systemic sclerosis Clin Rheumatol 21 2002 43 45
79. S.J. Wang, J.L. Lan, J.L. Lan, D.Y. Chen, Y.H. Chen, T.Y. Hsieh Effects of cisapride on colonic transit in patients with progressive systemic sclerosis Clin Rheumatol 21 2002 271 274
80. C. Enger, C. Cali, A.M. Walker Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States Pharmacoepidemiol Drug Saf 11 2002 477 486
81. J.T. Barbey, R. Lazzara, D.P. Zipes Spontaneous adverse event reports of serious ventricular arrhythmias, QT prolongation, syncope, and sudden death in patients treated with cisapride J Cardiovasc Pharmacol Ther 7 2002 65 76
82. G.E. Boeckxstaens, J.F.W.M. Bartelsman, L. Lauwers, G.N.J. Tytgat Treatment of GI dysmotility in scleroderma with the new enterokinetic agent prucalopride Am J Gastroenterol 97 2002 194 197
83. S. Appel-Dingemanse Clinical pharmacokinetics of tegaserod, a serotonin 5-HT(4) receptor partial agonist with promotile activity Clin Pharmacokinet 41 2002 1021 1042
84. M. Corsetti, J. Tack Tegaserod a new 5-HT(4) agonist in the treatment of irritable bowel syndrome Exp Opin Pharmacother 3 2002 1211 1218
85. M.A. Pilot Macrolides in roles beyond antibiotic therapy Br J Surg 81 1994 1423 1429
86. H.C. Soudah, W.L. Hasler, C. Owyang Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma N Eng J Med 325 1991 1461 1467
87. A. Malcolm, K. Ellard Intestinal perforation associated with octreotide therapy in scleroderma Am J Gastroenterol 96 2001 3206 3207
88. G.N. Verne, E.Y. Eaker, E. Hardy, C.A. Sninsky Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction Dig Dis Sci 40 1995 1892 1901
89. P.J. Clements Systemic sclerosis (scleroderma) and related disorders clinical aspects Baillieres Clin Rheumatol 14 2000 1 16
90. I. Lindsey, C.R. Farmer, I.G. Cunningham Subtotal colectomy and cecosigmoid anastomosis for colonic systemic sclerosis report of a case and review of the literature Dis Colon Rectum 46 2003 1706 1711
91. N.J. Kenefick, C.J. Vaizey, R.J. Nicholls, R. Cohen, M.A. Kamm Sacral nerve stimulation for faecal incontinence due to systemic sclerosis Gut 51 2002 881 883
92. N.J. Kenefick, C.J. Vaizey, R.C.G. Cohen, R.J. Nicholls, M.A. Kamm Medium-term results of permanent sacral nerve stimulation for faecal incontinence Br J Surg 89 2002 896 901
93. M. Camilleri Diagnosis and treatment of enteric neuromuscular diseases Clin Auton Res 13 2003 10 15
94. H. Poormoghim, M. Lucas, N. Fertig, T.A. Medsger Jr Systemic sclerosis sine scleroderma. Demographic, clinical and serologic features and survival in forty-eight patients Arthritis Rheum 43 2000 444 451
95. V.D. Steen, T.A. Medsger Jr The value of the health assessment questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time Arthritis Rheum 40 1997 1984 1991